Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro A de Alarcon

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Hematology|July 12, 2002
Platelet spherocytosis: a new bleeding disorderJames G White, Pedro A de Alarcon
Pediatric Research|January 20, 2021
Evaluation of angiogenic signaling molecules associated with reactive thrombocytosis in an iron-deficient rat modelJessica Garcia, Peggy Mankin, Manu Gnanamony, et al.
Journal of Pediatric Hematology/Oncology|April 8, 2003
Pediatric sinovenous thrombosisM Cris Johnson, Nikki Parkerson, Sarah Ward, et al.
International Journal of Molecular Sciences|May 7, 2025
Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death PathwaysManu Gnanamony, Maria Thomas, Thu Hien Nguyen, et al.
Journal of Pediatric Hematology/Oncology|February 2, 2010
Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patientsSarah E Leary, Virginia L Harrod, Pedro A de Alarcon, et al.
Pediatric Blood & Cancer|November 29, 2023
SARS-CoV-2 vaccination response in pediatric oncology patientsAmber Marie D'Souza, Maria Thomas, Manu Gnanamony, et al.
Cancers|June 19, 2024
Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk NeuroblastomaMaria Thomas, Thu Hien Nguyen, Jenny Drnevich, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group reportPeter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|July 12, 2002
Platelet spherocytosis: a new bleeding disorderJames G White, Pedro A de Alarcon
Pediatric Research|January 20, 2021
Evaluation of angiogenic signaling molecules associated with reactive thrombocytosis in an iron-deficient rat modelJessica Garcia, Peggy Mankin, Manu Gnanamony, et al.
Journal of Pediatric Hematology/Oncology|April 8, 2003
Pediatric sinovenous thrombosisM Cris Johnson, Nikki Parkerson, Sarah Ward, et al.
International Journal of Molecular Sciences|May 7, 2025
Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death PathwaysManu Gnanamony, Maria Thomas, Thu Hien Nguyen, et al.
Journal of Pediatric Hematology/Oncology|February 2, 2010
Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patientsSarah E Leary, Virginia L Harrod, Pedro A de Alarcon, et al.
Pediatric Blood & Cancer|November 29, 2023
SARS-CoV-2 vaccination response in pediatric oncology patientsAmber Marie D'Souza, Maria Thomas, Manu Gnanamony, et al.
Cancers|June 19, 2024
Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk NeuroblastomaMaria Thomas, Thu Hien Nguyen, Jenny Drnevich, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group reportPeter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pageof 3